A Review of Advances in Bioanalytical Methods for the Detection and Quantification of Olanzapine and Its Metabolites in Complex Biological Matrices

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2024 Mar 28

PMID 38543189

Authors

Anna Czyz

Alicja Zakrzewska-Sito

Julita Kuczynska

Affiliations

Soon will be listed here.

Abstract

Schizophrenia is a serious mental disorder that significantly affects the social and professional life of patients, causing distortion of reality and loss of identity and cognitive abilities. Psychopharmacological treatment is an integral part of modern psychiatry, and the introduction of new "atypical" antipsychotic drugs has brought significant progress in the treatment of this disorder. One of these drugs is olanzapine, which has an effective effect on the productive symptoms of schizophrenia while having an almost minimal potential to cause extrapyramidal syndrome. However, its effectiveness is confronted with frequent side effects, referred to as "metabolic disorders". Therefore, to ensure the effectiveness of treatment and to minimize the side effects caused by olanzapine, it is recommended to monitor the drug level during therapy. This article reviews the bioanalytical methodologies that enable efficient extraction and sensitive analysis of olanzapine. We considered the advantages and disadvantages of different sample pretreatment methods, including traditional and novel strategies. The analytical conditions required for the separation and detection of olanzapine and its metabolites were analyzed using chromatographic methods combined with various detectors.

References

Zheng Q, Wang F, Li H, Xu P, Tang H, Li L . Quantitative analysis of olanzapine in rat brain microdialysates by HPLC-MS/MS coupled with column-switching technique. J Chromatogr B Analyt Technol Biomed Life Sci. 2012; 905:127-32. DOI: 10.1016/j.jchromb.2012.07.024. View

Bao J, Potts B . Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl. 2001; 752(1):61-7. DOI: 10.1016/s0378-4347(00)00518-1. View

Badawy M, El-Nouby M, Kimani P, Lim L, Rabea E . A review of the modern principles and applications of solid-phase extraction techniques in chromatographic analysis. Anal Sci. 2022; 38(12):1457-1487. PMC: 9659506. DOI: 10.1007/s44211-022-00190-8. View

Jiang H, Cao H, Zhang Y, Fast D . Systematic evaluation of supported liquid extraction in reducing matrix effect and improving extraction efficiency in LC-MS/MS based bioanalysis for 10 model pharmaceutical compounds. J Chromatogr B Analyt Technol Biomed Life Sci. 2012; 891-892:71-80. DOI: 10.1016/j.jchromb.2012.02.031. View

Fisher D, Partridge S, Handley S, Couchman L, Morgan P, Flanagan R . LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic Sci Int. 2013; 229(1-3):145-50. DOI: 10.1016/j.forsciint.2013.02.010. View

Du P, Li P, Zhao R, Liu H, Liu L . Optimized UPLC-MS/MS method for the quantitation of olanzapine in human plasma: application to a bioequivalence study. Bioanalysis. 2019; 11(13):1291-1302. DOI: 10.4155/bio-2019-0114. View

Ikeda K, Ikawa K, Kozumi T, Yokoshige S, Horikawa S, Morikawa N . Development and validation of a GC-EI-MS method with reduced adsorption loss for the quantification of olanzapine in human plasma. Anal Bioanal Chem. 2012; 403(7):1823-30. DOI: 10.1007/s00216-012-5802-4. View

Bymaster F, Perry K, Nelson D, Wong D, Rasmussen K, Moore N . Olanzapine: a basic science update. Br J Psychiatry Suppl. 1999; (37):36-40. View

Heller S, Hiemke C, Stroba G, Rieger-Gies A, Daum-Kreysch E, Sachse J . Assessment of storage and transport stability of new antidepressant and antipsychotic drugs for a nationwide TDM service. Ther Drug Monit. 2004; 26(4):459-61. DOI: 10.1097/00007691-200408000-00019. View

10.

Miroshnichenko I, Baymeeva N . Simultaneous Determination of Antipsychotic Drugs and Their Active Metabolites by LC-MS-MS and its Application to Therapeutic Drug Monitoring. J Chromatogr Sci. 2018; 56(6):510-517. DOI: 10.1093/chromsci/bmy024. View

11.

Andreassen T, Falch B, Spigset O . A UPLC-MSMS method for the analysis of olanzapine in serum-with particular emphasis on drug stability testing. J Chromatogr B Analyt Technol Biomed Life Sci. 2015; 1006:112-120. DOI: 10.1016/j.jchromb.2015.10.029. View

12.

Patteet L, Cappelle D, Maudens K, Crunelle C, Sabbe B, Neels H . Advances in detection of antipsychotics in biological matrices. Clin Chim Acta. 2014; 441:11-22. DOI: 10.1016/j.cca.2014.12.008. View

13.

Sachse J, Koller J, Hartter S, Hiemke C . Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spectrophotometric detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 830(2):342-8. DOI: 10.1016/j.jchromb.2005.11.032. View

14.

Callaghan J, Bergstrom R, Ptak L, Beasley C . Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet. 1999; 37(3):177-93. DOI: 10.2165/00003088-199937030-00001. View

15.

Samanidou V, Stathatos C, Njau S, Kovatsi L . Disposable pipette extraction for the simultaneous determination of biperiden and three antipsychotic drugs in human urine by GC-nitrogen phosphorus detection. Bioanalysis. 2012; 5(1):21-9. DOI: 10.4155/bio.12.292. View

16.

Barbosa J, Faria J, Carvalho F, Pedro M, Queiros O, Moreira R . Hair as an alternative matrix in bioanalysis. Bioanalysis. 2013; 5(8):895-914. DOI: 10.4155/bio.13.50. View

17.

Dziurkowska E, Jimenez-Morigosa C, Lopez-Rivadulla M, Wesolowski M . Development and validation of solid-phase extraction coupled with a liquid chromatography-tandem mass spectrometry method for quantitation of olanzapine in saliva. J Chromatogr B Analyt Technol Biomed Life Sci. 2019; 1136:121896. DOI: 10.1016/j.jchromb.2019.121896. View

18.

Patteet L, Maudens K, Morrens M, Sabbe B, Dom G, Neels H . Determination of Common Antipsychotics in Quantisal-Collected Oral Fluid by UHPLC-MS/MS: Method Validation and Applicability for Therapeutic Drug Monitoring. Ther Drug Monit. 2015; 38(1):87-97. DOI: 10.1097/FTD.0000000000000242. View

19.

Berna M, Shugert R, Mullen J . Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry. J Mass Spectrom. 1998; 33(10):1003-8. DOI: 10.1002/(SICI)1096-9888(1998100)33:10<1003::AID-JMS716>3.0.CO;2-P. View

20.

Bymaster F, Calligaro D, Falcone J, Marsh R, Moore N, Tye N . Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 1996; 14(2):87-96. DOI: 10.1016/0893-133X(94)00129-N. View